Applied Ventures

Applied Ventures, LLC, established in 2001, is the venture capital arm of Applied Materials, Inc., a global leader in nanomanufacturing technology solutions for the electronics industry. Based in Santa Clara, California, Applied Ventures invests in early-stage technology companies that align with its parent's core expertise in semiconductors, displays, solar PV, and related products. The firm seeks innovative startups in advanced materials, display technologies, energy conservation, artificial intelligence, life sciences, and sustainability sectors, aiming to profitably invest in high-growth, high-return opportunities that complement and extend Applied Materials' core business.

Blair Georgakas

Investment Manager

Anand Kamannavar

Vice President and Global Head

Steven Konsek Ph.D

Investment Director

Jackie Kossmann

Investor

Frank Lee

Senior Investment Director

Brad McManus

Senior Investment Director

Omkaram Nalamasu Ph.D

President, Senior Vice President and CTO

Rajesh Ramanujam

Investment Director

John Wei Ph.D

Investment Director

Rajesh Ramanujam

Investment Director

Past deals in Nanotechnology

Scintil Photonics

Venture Round in 2022
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.

Exo

Series B in 2020
Exo is a medical device startup focused on revolutionizing ultrasound technology for imaging and therapeutic applications. The company has developed a handheld ultrasound platform that integrates advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost advantages of semiconductor manufacturing. This approach allows Exo to provide high-quality, affordable, and user-friendly medical imaging solutions. By enabling healthcare professionals to make critical, real-time decisions, Exo aims to enhance patient outcomes significantly. The company's commitment to accessibility and ease of use in medical imaging represents a significant advancement in the field, making effective diagnostic tools available at an unprecedented price point.

Inpria

Series C in 2020
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Exo

Series A in 2017
Exo is a medical device startup focused on revolutionizing ultrasound technology for imaging and therapeutic applications. The company has developed a handheld ultrasound platform that integrates advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost advantages of semiconductor manufacturing. This approach allows Exo to provide high-quality, affordable, and user-friendly medical imaging solutions. By enabling healthcare professionals to make critical, real-time decisions, Exo aims to enhance patient outcomes significantly. The company's commitment to accessibility and ease of use in medical imaging represents a significant advancement in the field, making effective diagnostic tools available at an unprecedented price point.

Inpria

Series B in 2017
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Exo

Venture Round in 2017
Exo is a medical device startup focused on revolutionizing ultrasound technology for imaging and therapeutic applications. The company has developed a handheld ultrasound platform that integrates advanced nano-materials, innovative sensor technologies, and sophisticated signal processing with the cost advantages of semiconductor manufacturing. This approach allows Exo to provide high-quality, affordable, and user-friendly medical imaging solutions. By enabling healthcare professionals to make critical, real-time decisions, Exo aims to enhance patient outcomes significantly. The company's commitment to accessibility and ease of use in medical imaging represents a significant advancement in the field, making effective diagnostic tools available at an unprecedented price point.

Inpria

Venture Round in 2014
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Inpria

Venture Round in 2014
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Iosil Energy

Private Equity Round in 2012
Iosil Energy Corporation specializes in the production and marketing of high-purity polysilicon, a critical raw material for solar cells. Founded in 2007 and headquartered in Groveport, Ohio, the company has established research and development facilities at the National Institute for Nanotechnology in Edmonton, Alberta. Iosil Energy utilizes innovative technology to purify silicon from waste material generated by wafer sawing operations, known as "kerf." This process not only enhances the purity of the polysilicon produced but also reduces energy consumption and equipment requirements, allowing for a more cost-effective solution for clients in the solar industry.

ActaCell

Series A in 2008
ActaCell, Inc. is a technology start-up focused on commercializing advanced lithium-ion battery technology developed at The University of Texas at Austin. The company's innovations aim to provide significantly longer cycle life at a lower cost while prioritizing safety. ActaCell's energy storage solutions utilize a nanocomposite alloy anode material as a replacement for traditional graphite, enhancing efficiency and longevity in high-energy applications. The company secured $5.8 million in Series A financing in July 2008, led by DFJ Mercury and supported by investors such as Google.org's RechargeIT program and Applied Ventures, LLC. These funds are intended to recruit essential technical talent and further advance ActaCell's battery technology for commercial use.

Plextronics

Venture Round in 2007
Plextronics specializes in the development of printed electronics, focusing on organic light-emitting diode (OLED) displays and lighting. The company creates conductive inks and associated process technologies that facilitate the mass production of printed devices, thereby reducing costs. Additionally, Plextronics is involved in the development of active layer technology for organic solar cells and plastic circuitry, further enhancing its portfolio in the realm of advanced electronic materials.

Grandis

Venture Round in 2005
Grandis is a pioneer in the development and licensing of innovative non-volatile memory solutions based on advanced research in spintronics. The company specializes in spin transfer torque random access memory products, which are designed to store, manipulate, and transmit information for the semiconductor industry. Grandis licenses these products to technology companies engaged in the design, development, and manufacturing of consumer electronics, personal computers, as well as equipment used in automotive, medical, military, and space applications. The company's mission is to facilitate the creation of revolutionary products through the application of the electron's spin.

Grandis

Series A in 2003
Grandis is a pioneer in the development and licensing of innovative non-volatile memory solutions based on advanced research in spintronics. The company specializes in spin transfer torque random access memory products, which are designed to store, manipulate, and transmit information for the semiconductor industry. Grandis licenses these products to technology companies engaged in the design, development, and manufacturing of consumer electronics, personal computers, as well as equipment used in automotive, medical, military, and space applications. The company's mission is to facilitate the creation of revolutionary products through the application of the electron's spin.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.